Home › Funds › Eukles Asset Management › LH

Eukles Asset Management position in LH

LABCORP HOLDINGS INC · Health Care

Eukles Asset Management reported holding 14,173 shares of LH (LABCORP HOLDINGS INC) in its Q3 2026 13F filing — a position valued at US$4.4M, representing 1.74% of its reported portfolio and ranking #17 among its reported holdings. Eukles Asset Management has disclosed LH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)14.17K sh
Reported value held$4.37M
Portfolio Weight1.74%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Eukles Asset Management's LH position evolved

Eukles Asset Management first disclosed a stake in LH in Q3 2023 at 17,379 shares (US$3.5M). The position peaked in Q3 2025 at 16,971 shares, worth US$4.9M. Across 13 filings, Eukles Asset Management increased the stake 2 time(s), trimmed it 5 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 14,173 shares valued at US$4.4M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 17.38K $3.49M New
Q4 2023 17.40K $3.96M Hold
Q1 2024 18.00K $3.93M Add
Q2 2024 18.06K $3.68M Hold
Q3 2024 17.82K $3.98M Reduce
Q4 2024 16.88K $3.87M Reduce
Q1 2025 17.11K $3.98M Add
Q2 2025 17.02K $4.47M Hold
Q3 2025 16.97K $4.87M Hold
Q4 2025 16.86K $4.23M Reduce
Q1 2026 14.68K $3.92M Reduce
Q2 2026 14.24K $3.99M Reduce
Q3 2026 14.17K $4.37M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LH and 13F data

LH (LABCORP HOLDINGS INC) is a Health Care company. 27 other funds we track also report a position in LH — the largest reported positions include VICTORY CAPITAL MANAGEMENT INC (US$1.21B), Boston Partners (US$908.7M), Allspring Global Investments Holdings, LLC (US$632.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LH

All LH fund holders →

FAQ

How long has Eukles Asset Management held LH?

Eukles Asset Management has disclosed LH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Eukles Asset Management's current position in LH?

As of Q3 2026, Eukles Asset Management holds 14.17K shares of LH (LABCORP HOLDINGS INC), valued at $4.37M, representing 1.74% of its reported portfolio and ranking #17.

Has Eukles Asset Management been buying or selling LH?

In the latest 13F filing (Q3 2026), Eukles Asset Management held unchanged its position in LH. The position peaked in Q3 2025 at 16.97K shares.

Which other funds hold LH?

Other major institutional holders of LH include VICTORY CAPITAL MANAGEMENT INC, Boston Partners, Allspring Global Investments Holdings, LLC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.